Basics Eton Pharmaceuticals, Inc. Common Stock IPO Date: November 13, 2018 Sector: Healthcare Industry: Drug Manufacturers - Specialty and Generic Market Cap: $473.87M Activated in VL: True Average Daily Range Avg Daily Range: $0.18 | 2.74% Avg Daily Range (30 D): $0.26 | 1.62% Avg Daily Range (90 D): $0.39 | 2.37% Institutional Daily Volume Avg Daily Volume: .2M Avg Daily Volume (30 D): .26M Avg Daily Volume (90 D): .35M Trade Size Avg Trade Size (Sh.): 118 Avg Trade Size (Sh.) (30 D): 58 Avg Trade Size (Sh.) (90 D): 65 Institutional Trades Total Inst.Trades: 48 Avg Inst. Trade: $2.06M Avg Inst. Trade (30 D): $1M Avg Inst. Trade (90 D): $2.24M Avg Inst. Trade Volume: .2M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.07M Avg Closing Trade (30 D): $.96M Avg Closing Trade (90 D): $2.91M Avg Closing Volume: 294.74K     News May 9, 2024 @ 8:01 PM Eton Pharmaceuticals Reports First Quarter 2024 Fi... Source: Eton Pharmaceuticals May 1, 2024 @ 8:05 PM Eton Pharmaceuticals to Present at the Citizens JM... Source: Eton Pharmaceuticals Apr 30, 2024 @ 11:00 AM Eton Pharmaceuticals Announces Submission to FDA o... Source: Eton Pharmaceuticals Apr 29, 2024 @ 8:30 PM Eton Pharmaceuticals to Report First Quarter 2024 ... Source: Eton Pharmaceuticals Mar 22, 2024 @ 6:00 AM Eton Pharmaceuticals Announces Acquisition of PKU... Source: Eton Pharmaceuticals Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.1 $-.06 $-.03 Diluted EPS Revenue $ 18.93M $ 17.28M $ 11.65M Gross Profit $ 11.92M $ 9.86M $ 6.48M Net Income / Loss $ -2.59M $ -1.57M $ -.6M Operating Income / Loss $ -1.48M $ -.47M $ .63M Cost of Revenue $ 7M $ 7.42M $ 5.17M Net Cash Flow $ M $ M $ -5.33M PE Ratio